GAMIFANT
Emaco Sa
Mark For: GAMIFANT® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87283834 |
| Registration Number | 5505933 |
| Mark Literal Elements | GAMIFANT |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | PUBLICATION AND ISSUE SECTION 2018-07-03 |
| Basis | 44(e) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | No |
| Filed ITU | Yes |
| 44D Filed | Yes |
| 44E Current | Yes |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Domestic Representative | Janet L. Cullum |
| Attorney Name | Janet L. Cullum |
| Attorney Docket Number | 322145-20000 |
| Law Office Assigned | L50 |
| Employee Name | LEE, JEANIE H |
Timeline
| 2016-12-29 | Application Filed |
| 2018-04-17 | Published |
| 2018-04-17 | Published for Opposition |
| 2018-07-03 | Location: PUBLICATION AND ISSUE SECTION |
| 2018-07-03 | Status: Live/Registered |
| 2018-07-03 | Status: Registered. The registration date is used to determine when post-registration maintenance documents are due. |
| 2018-07-03 | Trademark Registered |
| 2019-07-18 | Transaction Date |
| 2023-07-03 | Maintenance Early File Date |
| 2024-07-03 | Maintenance On Time Date |
| 2025-01-03 | Maintenance Late Fee Date |
Trademark Parties (Applicants & Owners)
| Party: |  EMACO SA |
| Address | 14 CH. DES AULS 1228 PLAN LES OUATES GENEVA SWITZERLAND |
| Legal Entity Type | Corporation |
| Legal Entity State | SWITZERLAND |
Documents
 Drawing | JPEG | 2016-12-29 |
 TEAS RF New Application | MULTI | 2016-12-29 |
| Notation to File | XML | 2017-03-27 |
| Offc Action Outgoing | XML | 2017-03-27 |
| XSearch Search Summary | XML | 2017-03-27 |
| Response to Office Action | MULTI | 2017-09-27 |
| Amendment and Mail Process Complete | MULTI | 2017-10-13 |
| Offc Action Outgoing | XML | 2017-11-02 |
| Response to Office Action | MULTI | 2018-03-12 |
| Amendment and Mail Process Complete | MULTI | 2018-03-14 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2018-03-14 |
| Notice of Publication | XML | 2018-03-28 |
| Notification Of Notice of Publication | XML | 2018-03-28 |
| OG Publication Confirmation | XML | 2018-04-17 |
| Registration Certificate | 2018-07-03 |
Attorney of Record
Good, Services, and Codes
IC 001. US 001 005 006 010 026 046. G & S: Biochemicals, namely, polypeptides, superantigens, biomarkers and antibodies for medical and scientific research; cells, cell extracts and components of cells for medical and scientific research; diagnostic agents for medical and scientific research; diagnostic biomarker reagent for biomarker reagents for medical and scientific research; diagnostic test kits consisting primarily of biomarkers for medical and scientific research; biochemical test kits consisting of assays and reagents for medical and scientific research purposes
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical and biological preparations to treat immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; pharmaceutical and biological preparations based on polypeptides, superantigens, biomarkers and antibodies to treat immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; Pharmaceutical and biological preparations and immunotherapies being medical preparations for stimulating the immune response, all for use in the diagnosis, prevention, management and treatment of immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; therapeutic and diagnostic agents, preparations and substances for medical purpose for use in therapies for immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; biochemical substance, polypeptides, antibodies, biomarkers and superantigens for use in diagnoses and therapies for immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; engineered cell therapies, namely engineered T cells, immune cells, and antibodies for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic test kits consisting primarily of biomarkers for medical purposes; biochemical test kits comprised of assays and reagents for medical, diagnostic and therapeutic purposes
| International Codes: | 1 |
| U.S. Codes: | 001,005,006,010,026,046 |
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0011 | Biochemicals, namely, polypeptides, superantigens, biomarkers and antibodies for medical and scientific research; cells, cell extracts and components of cells for medical and scientific research; diagnostic agents for medical and scientific research; diagnostic biomarker reagent for biomarker reagents for medical and scientific research; diagnostic test kits consisting primarily of biomarkers for medical and scientific research; biochemical test kits consisting of assays and reagents for medical and scientific research purposes |
Assignments
| Description | Date |
|---|---|
 Trademark Assignment 6691-0537 [7 Pages] | 2019-07-11 |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2019-07-17 | |
| REGISTERED-PRINCIPAL REGISTER | 2018-07-03 | |
| PUBLISHED FOR OPPOSITION | 2018-04-17 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-04-17 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-03-28 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2018-03-13 | 88889 |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-03-13 | |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2018-03-12 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2018-03-12 | 88889 |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-11-02 | 6325 |
| NON-FINAL ACTION WRITTEN | 2017-11-02 | 88570 |
| NON-FINAL ACTION E-MAILED | 2017-11-02 | 6325 |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2017-10-12 | 73797 |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2017-10-12 | 73797 |
| ASSIGNED TO LIE | 2017-10-10 | 73797 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2017-09-27 | |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2017-03-27 | 6325 |
| NON-FINAL ACTION WRITTEN | 2017-03-27 | 88570 |
| NON-FINAL ACTION E-MAILED | 2017-03-27 | 6325 |
| ASSIGNED TO EXAMINER | 2017-03-27 | 88570 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-01-10 | |
| NEW APPLICATION ENTERED IN TRAM | 2017-01-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 